Bloomberg News

Protalix BioTherapeutics Advances to 3-Month High in Tel Aviv

October 25, 2011

Oct. 25 (Bloomberg) -- Protalix BioTherapeutics Inc. climbed to the highest level in almost three months in Tel Aviv, jumping 5.4 percent to 22.89 shekels at 9:56 a.m., the highest since Aug. 2.

The U.S.-traded shares surged 14 percent to $6.13 yesterday, the equivalent of 22.39 shekels.

To contact the reporter on this story: Susan Lerner in Jerusalem at slerner2@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus